Literature DB >> 3440873

Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage.

T Miike1, S Sugino, Y Ohtani, K Taku, K Yoshioka.   

Abstract

Blood vessels in muscle biopsy specimens from 4 Duchenne muscular dystrophy (DMD) patients (including 3 at the preclinical stage) were examined by electron microscopy and compared with those in non-diagnostic biopsy specimens from age-matched controls and cases of other childhood neuromuscular disorders. The most striking feature was the blister-like swelling of vascular endothelial cells in the biopsied muscle specimens from the 3 preclinical stage DMD patients, which was observed in 23-39% of the small blood vessels examined. Other noticeable features in the preclinical DMD patients were: (1) replication of the basement membrane, there being more than 3 layers in 30% of the capillaries; (2) many degenerating and regenerating capillaries; and (3) platelet adhesion and aggregation in small blood vessels including small arteries and veins. Morphometric analysis showed that the capillary and endothelial cell areas were much greater in the preclinical DMD patients than in the controls or the cases of the other neuromuscular disorders. These phenomena strongly suggest an as yet undetermined process in blood vessels in preclinical DMD.

Entities:  

Mesh:

Year:  1987        PMID: 3440873     DOI: 10.1016/0022-510x(87)90007-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Authors:  Zoe White; Chady H Hakim; Marine Theret; N Nora Yang; Fabio Rossi; Dan Cox; Gordon A Francis; Volker Straub; Kathryn Selby; Constadina Panagiotopoulos; Dongsheng Duan; Pascal Bernatchez
Journal:  J Clin Lipidol       Date:  2020-05-29       Impact factor: 4.766

2.  Microcirculation in skeletal muscle.

Authors:  Olga Hudlicka
Journal:  Muscles Ligaments Tendons J       Date:  2011-10-30

3.  Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.

Authors:  Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez
Journal:  J Lipid Res       Date:  2017-11-25       Impact factor: 5.922

4.  Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS.

Authors:  Hubert Dabiré; Inès Barthélémy; Nicolas Blanchard-Gutton; Lucien Sambin; Carolina Carlos Sampedrano; Vassiliki Gouni; Yves Unterfinger; Pablo Aguilar; Jean-Laurent Thibaud; Bijan Ghaleh; Alain Bizé; Jean-Louis Pouchelon; Stéphane Blot; Alain Berdeaux; Luc Hittinger; Valérie Chetboul; Jin Bo Su
Journal:  Basic Res Cardiol       Date:  2011-12-23       Impact factor: 17.165

5.  Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission.

Authors:  M F Mehler; K Z Haas; J A Kessler; P K Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

6.  Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Authors:  Ju Lan Chun; Robert O'Brien; Min Ho Song; Blake F Wondrasch; Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

7.  Experimental serotonin myopathy as an animal model of muscle degeneration and regeneration in muscular dystrophy.

Authors:  H Narukami; K Yoshioka; J Zhao; T Miike
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy.

Authors:  Paulina Podkalicka; Olga Mucha; Katarzyna Kaziród; Iwona Bronisz-Budzyńska; Sophie Ostrowska-Paton; Mateusz Tomczyk; Kalina Andrysiak; Jacek Stępniewski; Józef Dulak; Agnieszka Łoboda
Journal:  Biomedicines       Date:  2021-04-27

9.  Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Nadia Milad; Zoe White; Arash Y Tehrani; Stephanie Sellers; Fabio M V Rossi; Pascal Bernatchez
Journal:  Skelet Muscle       Date:  2017-09-12       Impact factor: 4.912

10.  Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy.

Authors:  Akihiro Asai; Nita Sahani; Masao Kaneki; Yasuyoshi Ouchi; J A Jeevendra Martyn; Shingo Egusa Yasuhara
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.